跳至主要内容
临床试验/JPRN-jRCT1080225219
JPRN-jRCT1080225219已完成1 期

A pharmacological study of tacrolimus ointment to assess effect on local safety

Maruho Co.,Ltd.0 个研究点目标入组 20 人开始时间: 2020年6月5日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Atopic dermatitis patients

排除标准

  • (1) Patients with a history of, or currently with any of the following diseases:
  • 1) malignact tumor
  • 2) Serious allergy (shock, anaphylactoid symptoms)
  • 3) Allergy to tacrolimus
  • 4) Cutaneous hypersensitivity to topical drugs (e.g., allergic contact dermatitis)
  • (2) Patients with any of the following diseases:
  • 1) Diseases considered inappropriate for study participation, such as serious cardiac, hepatic, renal, pulmonary, or hematologic diseases
  • 2) Severe renal dysfunction, severe hyperkalemia or symptoms caused by them
  • 3) ulcer or erosion clearly forming a plaque at the application site of the investigational drug
  • 4) Diseases with ichthyosis-like erythroderma (Netherton syndrome, etc.)
  • 5) Skin infections at the application site of the investigational
  • 6) Diseases that present with pyrexia
  • 7) Diseases that affect the evaluation of heat sensation, pain and pruritus (except for atopic dermatitis)

研究者

相似试验

A pharmacological study of tacrolimus ointment | 临床试验